DBX (NASDAQ: DBX) lists 2,000 RSUs; insider sold 4,000 shares

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC notice of proposed resale lists 2,000 restricted stock units of common stock associated with an issuer transaction dated 05/14/2025. The filing also documents recent 10b5-1 sales by Karen Peacock of 4,000 shares on 05/15/2026 for $106,018.80.

Insights

Corporate Securities Counsel

Notice shows planned resale of RSUs and a recent rule‑based insider sale.

The filing lists 2,000 restricted stock units with an issuer label dated 05/14/2025, indicating these RSUs are the securities identified for resale. The excerpt separately records 10b5-1 sales by Karen Peacock of 4,000 shares on 05/15/2026 for $106,018.80.

Timing and cash‑flow treatment beyond the reported sale price are not detailed in the provided excerpt; subsequent filings would state settlement or proceeds recipients if different from the seller.

Equity Compensation Specialist

RSU resale listed; recent sale executed under a 10b5-1 plan.

The entry labels the securities as Restricted Stock Units and shows an amount of 2,000, dated 05/14/2025. Separate transaction history records a 10b5-1 sale by Karen Peacock of 4,000 shares on 05/15/2026.

These items are administrative notifications of resale and prior rule‑based sales; their investor impact depends on future dispositions and any additional registration details that may follow.

Key Figures

RSUs listed for resale: 2,000 shares Recent insider sale: 4,000 shares Proceeds reported: $106,018.80 +1 more

4 metrics

RSUs listed for resale 2,000 shares Restricted Stock Units dated 05/14/2025

Recent insider sale 4,000 shares 10b5-1 sales by Karen Peacock on 05/15/2026

Proceeds reported $106,018.80 Sale amount tied to 4,000 shares on 05/15/2026

Broker/Intermediary Morgan Stanley Smith Barney LLC Named in the filing header

Key Terms

Form 144, 10b5-1, Restricted Stock Units

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for KAREN PEACOCK"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 2000 | 05/14/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/07/2026 - 04:37 PM Accepted by SEC EDGAR 07/07/2026 - 04:36 PM Learn about SEC filing dates

FAQ

What does DBX's Form 144 list for resale?

It lists 2,000 restricted stock units associated with an issuer entry dated 05/14/2025. The filing identifies the security type and the date tied to those units without additional pricing or proceeds details.

Did any insider sell DBX shares recently?

Yes. The filing records Karen Peacock executing 10b5-1 sales of 4,000 shares on 05/15/2026 for $106,018.80. The sale is reported as a completed transaction with the stated proceeds.

What is a 10b5-1 sale as shown in the DBX filing?

A 10b5-1 sale is a prearranged trading plan permitting scheduled sales. The excerpt shows Karen Peacock used such a plan to sell 4,000 shares on 05/15/2026.

Who is identified as the broker or intermediary in the filing?

The filing names Morgan Stanley Smith Barney LLC with location details. It lists the firm in connection with the securities to be sold but does not specify execution mechanics in the excerpt.

Does the Form 144 show proceeds going to the issuer or the seller?

The excerpt reports the sale proceeds of $106,018.80 for the 4,000 share sale by Karen Peacock. It does not state that the issuer received proceeds; proceeds are tied to the reported sale transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	57020.00	149771000	07/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/14/2025	Restricted Stock Units	Issuer			2000	05/14/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KAREN PEACOCK 50 Hawthorne Street San Francisco CA 94105	Common	05/15/2026	4000	106018.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)